Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 27 Schemes (14.55%)
Foreign Institutions
Held by 46 Foreign Institutions (4.48%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Mar 2026)
Net Profit:
-22 Million
Pharmaceuticals & Biotechnology
USD 717 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.02
-999,999.00%
2.63






